ANTHRA-DERM trademark

ANTHRA-DERM - Trademark Information

Trademark by Dermik Laboratories, Inc.

The ANTHRA-DERM trademark was assigned a Serial Number #72180075 – by the United States Patent and Trademark Office (USPTO). Trademark Serial Number is a unique ID to identify the ANTHRA-DERM mark in USPTO. The ANTHRA-DERM mark is filed in the category of Pharmaceuticals. The legal correspondent for ANTHRA-DERM trademark is MARGARET H BITLER, AVENTIS PHARMACEUTICALS INC, PO BOX 6800 ROUTE #202-206 N, (MAIL STOP: BW-D-335), BRIDGEWATER, NEW JERSEY UNITED STATES 88070800 . The current status of the ANTHRA-DERM filing is Registration cancelled because registrant did not file an acceptable declaration under Section 8..

Based on Dermik Laboratories, Inc., the ANTHRA-DERM trademark is used in the following business: Medicated Ointment for the Treatment of Psoriasis and Related Conditions.

TrademarkTok is the largest free online trademark search, trademark monitoring, and tracking platform. We provide online software to streamline the process, helping clients do trademark & patent searches, applications, and monitoring more automatically and efficiently. You can create a free account on TrademarkTok.com and monitor all of your trademarks from one convenient dashboard, and receive free status updates any time when the status is changed.

Have a Name, Slogan, or Logo to protect? TrademarkTok, an Experienced IP Agent Made It Easy - Trademark Registration in 180 Countries.

Set up your brands for success! The United States is the most difficult country in the world to register a trademark. The trademark process in the United States takes approximately one year and is fraught with pitfalls. Approximately 60% of all applications receive a refusal. Many of these refusals can be overcome by strategic work of an experienced IP consultant, but DIY-applications generally are NOT successful.

We have extensive expertise in intellectual property law, including but not limited to trademark, copyright, and patent matters in multiple countries. You can count on our vast experience in filing trademark applications and trademark maintenance to help get your trademark protected properly, cost-effectively and efficiently.

Select the Filing Country:

Trademark Registration in USA

$199

$199 + Govt Fee* (1 class)

STANDARD PACKAGE

Basic Direct-Hit Searchto help avoid obvious duplications of pre-existing marks.
Professional Preparationof your trademark application.
Electronic Deliveryof your trademark application with no need to wait for mail or dealing with paper files. This will qualify you the reduced government filing fee.
Free Search & Evaluation on Alternative Mark if Your Attorney Thinks There's an Issue with Your First Choice.

* The Trademark government fee will be charged when we submit your mark(s) to the Government Trademark Office, which is usually in the next few business days.

SERIAL NUMBER
72180075
WORD MARK
ANTHRA-DERM
CURRENT STATUS
Registration cancelled because registrant did not file an acceptable declaration under Section 8.
STATUS DATE
Saturday, May 07, 2005
FILING DATE
Wednesday, October 30, 1963
PRIORITY-CLAIM INTERNATIONAL FILING DEADLINE:

April 30, 1964
(PRIORITY CLAIM MUST BE FILED WITHIN SIX MONTHS OF FOREIGN FILING)
Trademarks are territorial. US trademark registration will not protect your trademark in a foreign country. If you have plan to protect your trademark internationally, see more options below :
REGISTRATION NUMBER
774417
REGISTER TYPE
Principal
TRADEMARK OWNER
Blue Bell, PENNSYLVANIA UNITED STATES
Owner Type: CORPORATION
TRADEMARK CORRESPONDENT
AVENTIS PHARMACEUTICALS INC, PO BOX 6800 ROUTE #202-206 N, (MAIL STOP: BW-D-335), BRIDGEWATER, NEW JERSEY UNITED STATES 88070800
Trademark Classification Information
CLASS INFO
Class 005 - Pharmaceuticals

First Use Anywhere:
First Use in Commerce:
Trademark Goods and Services Description
DESCRIPTION
Class 005 - Medicated Ointment for the Treatment of Psoriasis and Related Conditions

Start Trademark Search

Search Now

Current Status:

Registration cancelled because registrant did not file an acceptable declaration under Section 8.

5/7/2005